Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 4ILC | Q7NDN8 | The GLIC pentameric ligand-gated ion channel in complex with sulfates | |
| 1DLL | P04958 | The HC fragement of tetanus toxin complexed with lactose | |
| 6PW6 | Q2N0S6 | The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain | Envelope glycoprotein gp120, Envelope glycoprotein gp41, Broadly Neutralizing Antibody NC-Cow1 Heavy Chain |
| 6PW6 | 6PW6 | The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain | Envelope glycoprotein gp120, Envelope glycoprotein gp41, Broadly Neutralizing Antibody NC-Cow1 Heavy Chain |
| 1FV2 | P04958 | The Hc fragment of tetanus toxin complexed with an analogue of its ganglioside receptor GT1B | TETANUS TOXIN HEAVY CHAIN |
| 7O82 | P60063 | The L-arginine/agmatine antiporter from E. coli at 1.7 A resolution | |
| 5JSL | P00138 | The L16F mutant of cytochrome c prime from Alcaligenes xylosoxidans: Ferrous form | |
| 7CMI | J3KPF3 | The LAT2-4F2hc complex in complex with leucine | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 2 |
| 7CMI | Q9UHI5 | The LAT2-4F2hc complex in complex with leucine | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 2 |
| 7CMH | J3KPF3 | The LAT2-4F2hc complex in complex with tryptophan | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 2 |
| 7CMH | Q9UHI5 | The LAT2-4F2hc complex in complex with tryptophan | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 2 |
| 5GNZ | 5GNZ | The M3 mutant structure of Bgl6 | |
| 8C9Y | D8NA05 | The MK-RSL - sulfonato-calix[8]arene complex, H32 form | |
| 5ADU | P0ACD8 | The Mechanism of Hydrogen Activation by NiFe-hydrogenases | |
| 5ADU | P69739 | The Mechanism of Hydrogen Activation by NiFe-hydrogenases | |
| 8RZK | G0L004 | The Michaelis complex of ZgGH129 D486N from Zobellia galactanivorans with neo-b/k-oligo-carrageenan tetrasaccharide (beta-kappa neo-oligo-carrageenan DP4). | |
| 2V50 | P52002 | The Missing Part of the Bacterial MexAB-OprM System: Structural determination of the Multidrug Exporter MexB | |
| 7CVN | P09467 | The N-arylsulfonyl-indole-2-carboxamide-based inhibitors against fructose-1,6-bisphosphatase | |
| 7K1S | A0A076N502 | The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion. | Envelope glycoprotein B |
| 8C9Z | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, H32 form, citrate pH 6.0 | |
| 6Z5M | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, I23 form, Gly-HCl pH 2.2 | |
| 6Z5G | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, I23 form, citrate pH 4.0, solved by S-SAD | |
| 6Z60 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, CAPS pH 9.5 | |
| 6Z5W | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, MES pH 6.8 | |
| 6Z62 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, TRIS-HCl pH 8.5 | |
| 6Z5X | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, acetate pH 4.8 | |
| 6Z5Q | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P3 form, acetate pH 4.0 | |
| 8Q6A | A0A0S4TLR1 | The RSL-D32N - sulfonato-calix[8]arene complex, I213 form, citrate pH 4.0 | |
| 8Q6B | A0A0S4TLR1 | The RSL-D32N - sulfonato-calix[8]arene complex, I23 form, citrate pH 4.0, obtained by cross-seeding | |
| 8Q6C | A0A0S4TLR1 | The RSL-D32N - sulfonato-calix[8]arene complex, P63 form, acetate pH 4.0 | |
| 6Z5Z | A0A0S4TLR1 | The RSL-R6 - sulfonato-calix[8]arene complex, P213 form, TRIS-HCl pH 8.5 | |
| 6Z5P | A0A0S4TLR1 | The RSL-R8 - sulfonato-calix[8]arene complex, P3 form, TRIS-HCl pH 8.5 | |
| 7ALG | A0A0S4TLR1 | The RSLex - sulfonato-calix[8]arene complex, P3 form, acetate pH 4.0 | |
| 7X91 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496 | |
| 7X91 | 7X91 | The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496 | |
| 7X8Y | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159 | |
| 7X8Y | 7X8Y | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159 | |
| 7X8Z | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188 | |
| 7X8Z | 7X8Z | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188 | |
| 7X90 | 7X90 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326 | |
| 7X90 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326 | |
| 7X8W | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354 | |
| 7X8W | 7X8W | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354 | |
| 7X92 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445 | |
| 7X92 | 7X92 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445 | |
| 7X95 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
| 7X95 | 7X95 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
| 7X94 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
| 7X94 | 7X94 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
| 7X93 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 |
